IL166138A0 - 1-heterocyclylalkyl-3-sulfonylindole or indazole derivatives as 5-hydroxytryptamine-6 ligands - Google Patents

1-heterocyclylalkyl-3-sulfonylindole or indazole derivatives as 5-hydroxytryptamine-6 ligands

Info

Publication number: IL166138A0
Authority: IL; Israel
Prior art keywords: sulfonylindole; hydroxytryptamine; heterocyclylalkyl; ligands; indazole derivatives
Prior art date: 2002-07-18

Application number

IL16613805A

Other languages

English (en)

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-18

Filing date

2005-01-04

Publication date

2006-01-15

2005-01-04 Application filed by Wyeth Corp filed Critical Wyeth Corp

2006-01-15 Publication of IL166138A0 publication Critical patent/IL166138A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IL16613805A 2002-07-18 2005-01-04 1-heterocyclylalkyl-3-sulfonylindole or indazole derivatives as 5-hydroxytryptamine-6 ligands IL166138A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39695802P	2002-07-18	2002-07-18
PCT/US2003/022485 WO2004009548A1 (en)	2002-07-18	2003-07-17	1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands

Publications (1)

Publication Number	Publication Date
IL166138A0 true IL166138A0 (en)	2006-01-15

Family

ID=30770964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16613805A IL166138A0 (en)	2002-07-18	2005-01-04	1-heterocyclylalkyl-3-sulfonylindole or indazole derivatives as 5-hydroxytryptamine-6 ligands

Country Status (17)

Country	Link
US (2)	US6995176B2 (es)
EP (1)	EP1554244A1 (es)
JP (1)	JP2005536520A (es)
KR (1)	KR20050021494A (es)
CN (1)	CN100351236C (es)
AR (1)	AR040567A1 (es)
AU (1)	AU2003259158A1 (es)
BR (1)	BR0312759A (es)
CA (1)	CA2491248A1 (es)
EC (1)	ECSP055536A (es)
IL (1)	IL166138A0 (es)
MX (1)	MXPA05000649A (es)
NO (1)	NO20050014L (es)
RU (1)	RU2005104434A (es)
TW (1)	TW200401641A (es)
WO (1)	WO2004009548A1 (es)
ZA (1)	ZA200500435B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4323810B2 (ja) *	2001-04-20	2009-09-02	ワイス	５−ヒドロキシトリプトアミン−６リガンドとしてのヘテロシクリルオキシ−、−チオキシ−および−アミノベンザゾール誘導体
KR20030088507A (ko) *	2001-04-20	2003-11-19	와이어쓰	5-하이드록시트립타민-6 리간드로서의헤테로사이클릴알콕시-, -알킬티오- 및-알킬아미노벤즈아졸 유도체
AU2002319814A1 (en) *	2001-08-13	2003-03-03	E.I. Du Pont De Nemours And Company	Substituted 1h-dihydropyrazoles, their preparation and use
EP1479138A2 (en) *	2002-02-13	2004-11-24	Koninklijke Philips Electronics N.V.	Integrated semiconductor optical device, method and apparatus for manufacturing such a device
UA79504C2 (en) *	2002-11-07	2007-06-25	Organon Nv	Indols for treating diseases associated with androgen receptors
WO2004074243A2 (en) *	2003-02-14	2004-09-02	Wyeth	Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
AU2004303461B2 (en) *	2003-12-23	2011-04-28	H. Lundbeck A/S	2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
TWI391387B (zh) *	2004-05-12	2013-04-01	Eisai R&D Man Co Ltd	具有哌啶環之吲哚衍生物
AR052308A1 (es) *	2004-07-16	2007-03-14	Lundbeck & Co As H	Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
GB0422263D0 (en) *	2004-10-07	2004-11-10	Glaxo Group Ltd	Novel compounds
EP1647549A1 (en) *	2004-10-14	2006-04-19	Laboratoire Theramex	Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
EP1676841A1 (en) *	2004-12-30	2006-07-05	Esteve Laboratorios Dr. Esteve S.A.	Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
JPWO2006082872A1 (ja) *	2005-02-04	2008-06-26	エーザイ・アール・アンド・ディー・マネジメント株式会社	１−（ピペリジン−４−イル）−１ｈ−インドール誘導体
CN101175751B (zh) *	2005-05-11	2011-03-23	卫材R&D管理有限公司	具有哌啶环的吲哚衍生物的晶体和其制备方法
US20080227815A1 (en) *	2005-05-11	2008-09-18	Takahisa Sakaguchi	Crystal of Indole Derivative Having Piperidine Ring and Process for Production Thereof
WO2006121106A1 (ja) *	2005-05-11	2006-11-16	Eisai R & D Management Co., Ltd.	ピペリジン環を有するインドール誘導体の製造方法
JP4932717B2 (ja) *	2005-05-11	2012-05-16	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピペリジン環を有するインドール誘導体の製造方法
KR20080007649A (ko) *	2005-05-11	2008-01-22	에자이 알앤드디 매니지먼트 가부시키가이샤	피페리딘환을 가지는 인돌 유도체의 결정 및 그의 제조방법
TW200800959A (en) *	2005-06-10	2008-01-01	Wyeth Corp	Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
AR054393A1 (es) *	2005-06-17	2007-06-20	Lundbeck & Co As H	Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) *	2005-06-17	2009-12-08	H. Lundbeck A/S	2-(1H-indolylsulfanyl)-aryl amine derivatives
WO2006138549A1 (en)	2005-06-17	2006-12-28	Wyeth	Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
WO2007032833A1 (en) *	2005-08-15	2007-03-22	Wyeth	Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
JP5146766B2 (ja)	2005-08-15	2013-02-20	ワイス・エルエルシー	５−ヒドロキシトリプタミン−６リガンドとしての置換−３−スルホニルインダゾール誘導体
US7556776B2 (en) *	2005-09-08	2009-07-07	President And Fellows Of Harvard College	Microfluidic manipulation of fluids and reactions
AU2007235499A1 (en) *	2006-04-05	2007-10-18	Wyeth	Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
WO2007120596A1 (en) *	2006-04-12	2007-10-25	Wyeth	DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
TW200808740A (en) *	2006-06-09	2008-02-16	Wyeth Corp	Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
TW200811144A (en) *	2006-06-09	2008-03-01	Wyeth Corp	Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
TW200808741A (en) *	2006-06-09	2008-02-16	Wyeth Corp	6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
US20080262228A1 (en) *	2006-11-28	2008-10-23	Wyeth	Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof
TW200901974A (en)	2007-01-16	2009-01-16	Wyeth Corp	Compounds, compositions, and methods of making and using them
US20090012308A1 (en) *	2007-06-13	2009-01-08	Wyeth	Process for the manufacture of benzylsulfonylarenes
GB0715048D0 (en) *	2007-08-02	2007-09-12	Glaxo Group Ltd	Novel compounds
DE102009004245A1 (de) *	2009-01-09	2010-07-15	Bayer Schering Pharma Aktiengesellschaft	Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
WO2011044134A1 (en) *	2009-10-05	2011-04-14	Albany Molecular Research, Inc.	Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
US9067949B2 (en)	2011-01-19	2015-06-30	Albany Molecular Research, Inc.	Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
CN106045967B (zh) *	2015-04-08	2020-04-21	广东东阳光药业有限公司	取代杂环化合物及其在药物上的应用
CN106045966B (zh) *	2015-04-08	2020-04-21	广东东阳光药业有限公司	取代杂环化合物及其在药物上的应用
CN111116461B (zh) *	2019-12-26	2021-07-27	浙江工业大学	一种钯催化邻甲苯吡啶酰胺γ-C-(sp3)H硫/硒醚类化合物的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5567711A (en)	1995-04-19	1996-10-22	Abbott Laboratories	Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
AR008245A1 (es) *	1996-06-21	1999-12-29	Glaxo Group Ltd	Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
GB9613096D0 (en) *	1996-06-21	1996-08-28	Glaxo Group Ltd	Medicaments
AU3261097A (en) *	1996-06-21	1998-01-14	Glaxo Group Limited	Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
US6100291A (en) *	1998-03-16	2000-08-08	Allelix Biopharmaceuticals Inc.	Pyrrolidine-indole compounds having 5-HT6 affinity
GB9820113D0 (en) *	1998-09-15	1998-11-11	Merck Sharp & Dohme	Therapeutic agents
DK1355900T3 (da) *	2000-12-22	2006-09-11	Wyeth Corp	Heterocyclylalkylindol- eller -azaindolforbindelser som 5-hydroxytryptamin-6-ligander
JP4307073B2 (ja) *	2000-12-22	2009-08-05	ワイス	５−ヒドロキシトリプトアミン−６リガンドとしてのヘテロサイクルインダゾールおよびアザインダゾール化合物
EP1414442A1 (en) *	2001-08-07	2004-05-06	Smithkline Beecham Plc	3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
TW200400177A (en) *	2002-06-04	2004-01-01	Wyeth Corp	1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
MXPA06000701A (es) *	2003-07-23	2006-04-11	Wyeth Corp	Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.

2003
- 2003-07-08 TW TW092118582A patent/TW200401641A/zh unknown
- 2003-07-14 AR AR20030102531A patent/AR040567A1/es unknown
- 2003-07-17 US US10/621,698 patent/US6995176B2/en not_active Expired - Fee Related
- 2003-07-17 AU AU2003259158A patent/AU2003259158A1/en not_active Abandoned
- 2003-07-17 CA CA002491248A patent/CA2491248A1/en not_active Abandoned
- 2003-07-17 BR BR0312759-1A patent/BR0312759A/pt not_active IP Right Cessation
- 2003-07-17 MX MXPA05000649A patent/MXPA05000649A/es unknown
- 2003-07-17 EP EP03765725A patent/EP1554244A1/en not_active Withdrawn
- 2003-07-17 CN CNB038168634A patent/CN100351236C/zh not_active Expired - Fee Related
- 2003-07-17 JP JP2004523565A patent/JP2005536520A/ja active Pending
- 2003-07-17 WO PCT/US2003/022485 patent/WO2004009548A1/en not_active Ceased
- 2003-07-17 KR KR10-2005-7000840A patent/KR20050021494A/ko not_active Withdrawn
- 2003-07-17 RU RU2005104434/04A patent/RU2005104434A/ru not_active Application Discontinuation
2005
- 2005-01-03 NO NO20050014A patent/NO20050014L/no unknown
- 2005-01-04 IL IL16613805A patent/IL166138A0/xx unknown
- 2005-01-12 EC EC2005005536A patent/ECSP055536A/es unknown
- 2005-01-17 ZA ZA200500435A patent/ZA200500435B/xx unknown
- 2005-09-29 US US11/238,246 patent/US7589108B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
RU2005104434A (ru)	2005-07-20
US7589108B2 (en)	2009-09-15
NO20050014L (no)	2005-04-14
ZA200500435B (en)	2006-08-30
CA2491248A1 (en)	2004-01-29
AU2003259158A1 (en)	2004-02-09
US20040024023A1 (en)	2004-02-05
ECSP055536A (es)	2005-03-10
JP2005536520A (ja)	2005-12-02
EP1554244A1 (en)	2005-07-20
CN100351236C (zh)	2007-11-28
WO2004009548A1 (en)	2004-01-29
US20060030593A1 (en)	2006-02-09
CN1668590A (zh)	2005-09-14
BR0312759A (pt)	2005-04-26
US6995176B2 (en)	2006-02-07
AR040567A1 (es)	2005-04-13
MXPA05000649A (es)	2005-03-31
TW200401641A (en)	2004-02-01
KR20050021494A (ko)	2005-03-07

Publication	Publication Date	Title
IL166138A0 (en)	2006-01-15	1-heterocyclylalkyl-3-sulfonylindole or indazole derivatives as 5-hydroxytryptamine-6 ligands
ZA200500437B (en)	2006-08-30	1-heterocyclyalkyl-3-sulfonazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
IL157059A0 (en)	2004-02-08	1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
SI1509522T1 (sl)	2007-06-30	1-(aminoalkil)-3-sulfonilazaindoli kot ligandi 5-hidroksitriptamina-6
IL158445A0 (en)	2004-05-12	Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
PL370890A1 (en)	2005-05-30	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
IL155443A0 (en)	2003-11-23	1- aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
ZA200506416B (en)	2007-02-28	Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
IL162243A0 (en)	2005-11-20	Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
PL377609A1 (pl)	2006-02-06	Pochodne indazolu jako antagoniści CRF
IL156518A0 (en)	2004-01-04	Heteocyclylalkylindole or-azaindole compounds as 5-hydroxytryptamine-6 ligands
IL158448A0 (en)	2004-05-12	Heterocyclylalkoxy- alkylthio-and-alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
AU2003273885A1 (en)	2004-04-23	Morpholine-bridged indazole derivatives
AU2003209114A1 (en)	2003-09-04	Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
HK1076464A (en)	2006-01-20	1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
HK1074619A (en)	2005-11-18	1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
HK1056561A (en)	2004-02-20	1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
HK1060128A (en)	2004-07-30	Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
HK1060880A (en)	2004-08-27	Heterocyclylalkoxy-, -alkylthio- and - alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
HK1066002A (en)	2005-04-15	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
HK1071372A (en)	2005-07-15	1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
HK1076281A (en)	2006-01-13	Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
EG27149A (en)	2015-08-10	Pyrazole derivatives as anti-inflammatory-antimicrobial agent
HK1055969A (en)	2004-01-30	1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
AU2002334722A1 (en)	2003-04-14	Chroman derivatives as 5-hydroxytryptamine-6 ligands